Skip to main content
Clinical Trials/NCT03246035
NCT03246035
Completed
Not Applicable

A Prospective Randomized Pilot Trial to Reduce Readmission for Frail Elderly Patients With Acute Decompensated Heart Failure

Jewish General Hospital1 site in 1 country60 target enrollmentMarch 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Jewish General Hospital
Enrollment
60
Locations
1
Primary Endpoint
All-cause death, hospital readmission, or ED revisit
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

A randomized study designed to determine whether telephone based interventions can prevent return hospital visits for elderly and frail patients with acute symptoms of heart failure. Specifically, the intervention will improve patients ability to monitor and address self care of heart failure at home.

Detailed Description

Acute decompensated heart failure (ADHF) is a common illness in Canadian emergency departments (ED). The frail subset of elderly patients with ADHF is challenging to treat, use a large proportion of available resources, and are at higher risk for complications, including readmission to hospital after discharge. The investigators believe that by improving access to follow-up, optimizing self-care, and addressing the various cognitive and physical limitations of frailty, it will be possible to improve quality of life and reduce readmission rates for frail patients with ADHF.

Registry
clinicaltrials.gov
Start Date
March 1, 2018
End Date
March 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jonathan Afilalo

Researcher

Jewish General Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients who presented to the ED and who are being discharged with a primary or secondary diagnosis of ADHF
  • Frailty, defined as a FRAIL score \>=3/5 or Clinical Frailty Scale (CFS) score \>=5/9
  • Informed consent provided by the patient or proxy

Exclusion Criteria

  • Significant dementia or active delirium
  • Severe frailty, defined as a CFS score \>=8/9
  • Prohibitive language barrier
  • Primary address outside of Quebec
  • Patient deemed to be palliative or moribund by treating team

Outcomes

Primary Outcomes

All-cause death, hospital readmission, or ED revisit

Time Frame: 90 days

Secondary Outcomes

  • Frailty Index(90 days)
  • Informed consent validation (qualitative)(90 days)
  • Self-Care Index(90 days)
  • Rate of return visits to any ER for any medical issue(30 days)
  • Rate of admission to hospital at 90 days(90 days)
  • Heart Failure Symptom Scale(90 days)
  • Incidence of adverse effects from medication(90 days)
  • Recruitment rate(90 days)
  • Attrition rate(90 days)
  • All-cause death, hospital readmission, or ED revisit(1 year)

Study Sites (1)

Loading locations...

Similar Trials